Медицинская литература. Новинки

 

 

 

 

 

 

Гепатоцеллюлярный рак.. Классификации методов хирургического лечения

Вы можете загрузить полный текст статьи в формате pdf

Ключевые слова:

Литература:
1. Ferlay J., Shin YR., Bray F., Forman D. et al. Globocan 2008;
Cancer Incidence and Mortality Worldwide / IARC CancerBase
N 10. IARC. Lyon, 2010. P. 1027–1614.
2. Nordenstedt H., White D.L., ElSerag H.B. The changing pattern
of epidemiology in hepatocellular carcinoma // Dig. Liv. Dis.
2010. V. 42. (Suppl. 3). P. 206–214.
3. Злокачественные новообразования в России в 2009 году
(заболеваемость и смертность) / Под ред. Чиссова В.И.,
Старинского В.В., Петровой Г.В. М., 2011.
4. Serag H.B. Hepatocellular Carcinoma // N. Engl. J. Med. 2011.
V. 365. P. 1118–1127.
5. Shaw J.J., Shah S.A. Rising incidence and demographics a hepatocellular carcinoma in the USA: what does it mean? // Expert
Rev. Gastroenterol. Hepatology. 2011. V. 5. P. 365–370.
6. Давыдов М.И., Аксель Е.М. Заболеваемость злокачественными заболеваниями населения России и стран СНГ в 2008
г. // Вест. РОНЦ им. Н.Н. Блохина РАМН, 2010. Т. 21. № 2.
Приложение 1. С. 52–86.
7. Социальноэкономическое бремя гепатоцеллюлярной карциномы в России / Экспертный совет по здравоохранению
Комитета Совета Федерации по соц.политике и здравоохранению М. 2010. C. 4–26.
8. Llovet J.M., Bisceglie A.М., Bruх J. et al. Design and endpoints of
clinical trials in hepatocellular carcinoma // J. Natl. Cancer Inst.
2008. V. 100. P. 698–711.
9. De Lope, Tremosini S., Forner A., Reig M. et al. Management of
HCC // J. Hepatology. 2012. V. 56. P. 75–87.
10. The Brisbane 2000 terminology of hepatic anatomy and resections. The terminology committee of the IHPBA// H.P.B. 2000.
V. 2. P. 233–339.
11. Вишневский В.А., Кубышкин В.А., Чжао А.В., Икрамов Р.З.
Операции на печени: Руководство для врачей. М.: Мик
лош, 2003.
12. Патютко Ю.И. Хирургическое лечение злокачественных
опухолей печени. М.: Практическая медицина, 2005.
13. Гальперин Э.И. Лекции по гепатобилиарной хирургии.
М.: Видар, 2011.
14. Omata M., Lesmana L.A., Tateishi R., Cheh S.M. et al. Asian
Pacific Association for the Study of the Liver consensus recommendations in hepatocellular carcinoma // Hepatol.
International. 2010. V. 4. P. 439–474.
15. Готье С.В., Константинов Б.А., Цирюльникова О.М. Трансплантация печени. М.: Мед. инф. aгво, 2008.
16. Burra P., Freeman R. Trends in Liver transplantation 2011 //
J. Hepatology. 2012. V. 56. P. 101–111.
17. Cucchetti A., Piscaglia F., Caturelli E. et al. Comparison of recurrence of hepatocellular carcinoma after resection in patients with
cirrhosis to its occurrence in a surveilled cirrhotic population //
Ann. Surg. Oncol. 2009. V. 16. P. 413–422.
18. Qin LX., Tang ZY. Metastasis and Recurrence After Surgical
Resection of Hepatocellular carcinoma: Recent Progress in
Clinical and Related Basic Aspects // Cur. Cancer Ther. Rev.
2005. V. 1. P. 71–80.
19. Waidmann O., Hofmann W.P., Zenzem S., Trojan J. mTOR inhibitors and Sorafenib for recurrent hepatocellular carcinoma after
orthotopic liver transplantation // J. Hepatology. 2011. V. 54.
P. 396–398.
20. Hanish S.I., Knechtle S.J. Liver Transplantation for the Treatment of Hepatocellular carcinoma // Oncology. 2011. V. 25.
P. 261–271.
21. Livranghi T., Makisalo H., Line P.D. Treatment optitions in
Hepatocellular carcinoma today // Scand. J. Surgery. 2011.
V. 100. P. 22–29.
22. Huang J.W., HernandezAlejandro R., Croome K.P. LuNan Yan
et al. Surgical vs percutaneous radiofrequency ablation for hepatocellular carcinoma in dangereous locations // Wld J.
Gastroenterology. 2011. V. 17. P. 123–129.
23. Greten T.F., Korangy F. Radiofrequency ablation for the treatment of HCCMaybe much more than simple tumor destruction // J. Hepatology. 2010. V. 53. P. 775–776.
24. Ng K.K., Poon R.T., Chan S.C., Chok K.S. et al. High-intensity
focused ultrasound for hepatocellular carcinoma: a single-center
experience // Ann. Surg. 2011. V. 253. P. 981–987.
25. Hinz S., Egberts JH., Panser U., Schafmayer C. et al. Electrolytic
ablation is as effective as radiofrequency ablation in the treatment of artificial liver metastases in pig model // J. Surg. Oncol.
2008. V. 98. P. 135–138.
26. Pfrepper C., Dufour J.F. New Treatments for Hepatocellular carcinoma // Eur. Gastroenterol. Hepatol. Rev. 2011. V. 7. P. 74–76.
27. Maleux G., van Malenstein H., Vandecaveye V., Heye S. et al.
Transcatheter Chemoembolization of Unresectable Hepatocellular carcinoma: Current Knowledge and Future Directions
// Dig. Dis. 2009. V. 27. P. 157–163.
28. Carter S., Martin II C.G. Drugeluting bead theragy in primary
and metastatic disease of the liver // H.P.B. 2009. V. 11.
P. 541–550.
29. Dhanasekaran R., Kooby D.A., Staley C.A. et al. Comparison of
Conventional Transarterial Chemoembolization (TAGE) and
Chemoembolization with Doxorubicin Drug Eluting Beads
(DEB) for Unresectable Hepatocellular carcinoma (HCC) //
J. Surg. Oncology. 2010. V. 101. P. 476–480.
30. D’Avola D., Inarrairaeguni M., Bilbao J.I., Martinez-Cuesta A.
et al. A Retrospective Comparative Analysis of the Effect of
Y90radioembolizaton on the Survival of Patients with Unresectable Hepatocellular carcinoma // HepatoGastroenterology.
2009. V. 56. P. 1683–1688.
31. Sangro B., Inarrairaeguni M., Bilbao J.I. Radioembolization
for hepatocellular carcinoma // J. Hepatology. 2012. V. 56.
P. 464–473.
32. Itoh S., Ikeda Y., Kawanaka H., Okyama T. et al. Efficacy of
Surgical Microwave Therapy in Patients with Unresectable
Hepatocellular carcinoma // Ann. Surg. Oncology. 2011. V. 18.
P. 3650–3656.
33. GoughPalmer A.L., Gedroyc W.M.W. Laser ablation of hepatocellular carcinoma // Wld J. Gastroenterology. 2008. V. 14.
P. 7170–7174.
34. Gilsrtap K., Hu X., Lu X., He X. Nanotechnology for energybased cancer therapies // Am. J. Cancer Res. 2011. V. 1.
P. 508–520.
35. Reddy L.H., Couvreur P. Nanotechnology for therapy and imaging of Liver diseases // J. Hepatology. 2001. V. 55. P. 1461–1466.
36. Alexander H.R., Bartlett D. by Fauber J. Liver cancer Treatment
Turns Up the Heat chemotherapy // http:www.Medpagetoday.com. 27.10.2011.
37. Awad T., Ghorlund K., Gluud C. Cryotherapy for hepatocellular
carcinoma // Cochrane Database Syst. Rev. 2009; (4): CD007611.

Hepatocellular Carcinoma. Surgical Management Classifications

Keywords: